loading
Quince Therapeutics Inc stock is traded at $1.68, with a volume of 61,019. It is down -0.59% in the last 24 hours and up +10.53% over the past month. Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
See More
Previous Close:
$1.69
Open:
$1.66
24h Volume:
61,019
Relative Volume:
0.18
Market Cap:
$76.39M
Revenue:
-
Net Income/Loss:
$-31.39M
P/E Ratio:
-2.00
EPS:
-0.84
Net Cash Flow:
$-18.45M
1W Performance:
-9.19%
1M Performance:
+10.53%
6M Performance:
+4.35%
1Y Performance:
+125.87%
1-Day Range:
Value
$1.63
$1.70
1-Week Range:
Value
$1.62
$1.87
52-Week Range:
Value
$0.5116
$2.45

Quince Therapeutics Inc Stock (QNCX) Company Profile

Name
Name
Quince Therapeutics Inc
Name
Phone
415-910-5717
Name
Address
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Name
Employee
36
Name
Twitter
Name
Next Earnings Date
2025-03-24
Name
Latest SEC Filings
Name
QNCX's Discussions on Twitter

Compare QNCX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
QNCX
Quince Therapeutics Inc
1.68 88.12M 0 -31.39M -18.45M -0.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-24-25 Initiated Oppenheimer Outperform

Quince Therapeutics Inc Stock (QNCX) Latest News

pulisher
12:21 PM

Can trapped investors hope for a rebound in Quince Therapeutics Inc.Free AI Driven Buy Alert Trade Blueprint - Newser

12:21 PM
pulisher
Aug 01, 2025

Published on: 2025-08-01 20:05:00 - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

Is Quince Therapeutics Inc. a growth stock or a value stockValue Investing Guidance To Watch Now - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Should you hold or exit Quince Therapeutics Inc. nowPortfolio Booster Strategy with Trend Confidence - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

What are analysts’ price targets for Quince Therapeutics Inc. in the next 12 monthsBreakout Stocks Opportunities Backed By Experts - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Is Quince Therapeutics Inc. stock bottoming outDaily Market Momentum and Pressure Analysis - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Using RSI to spot recovery in Quince Therapeutics Inc.Free Short Term Buy List With Stop Protection - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What makes Quince Therapeutics Inc. stock price move sharplyAI Generated Buy/Sell Signal Forecast - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What Fibonacci levels say about Quince Therapeutics Inc. reboundShort Term Opportunity Finder with Tools - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 23:00:54 - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Exit strategy if you’re trapped in Quince Therapeutics Inc.Free Risk Adjusted Technical Entry Plan - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

How Quince Therapeutics Inc. stock performs during market volatilityReal-Time Market Sentiment Tracking Gains Momentum - beatles.ru

Jul 29, 2025
pulisher
Jul 29, 2025

Wyckoff Accumulation Phase Possible in Quince Therapeutics Inc.Potential Breakout Stock List Published This Week - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

New Product Launches: Will They Boost Quince Therapeutics Inc. Stock in 2025Safe and Scalable Return Strategy Blueprint - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Sector ETF Data Correlates with Strength in Quince Therapeutics Inc.Intraday Trend Analysis for Fast Gains Released - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Quince Therapeutics Inc. Recovers — But Is It SustainableConservative Entry for High Return Setup Backed - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Quince Therapeutics Inc. stockAchieve rapid wealth accumulation with smart picks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Quince Therapeutics Inc. company’s growth strategyCapitalize on fast-growing investment opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Quince Therapeutics Inc.Unlock exclusive trading strategies for gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Quince Therapeutics Inc. stock price move sharply Free Intraday Trend Analysis for Fast Gains - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How does Quince Therapeutics Inc. compare to its industry peersFree Stock Movement Tracking - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How Quince Therapeutics Inc. stock performs during market volatility Long Hold Investment Strategy with Growth Focus - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

Why is Quince Therapeutics Inc. stock attracting strong analyst attentionInvest smarter with real-time trading alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive Quince Therapeutics Inc. stock higher in 2025Free Investment Case Studies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Quince Therapeutics Inc.Double or triple returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Has Quince Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewFree Stock Selection - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives $8.00 Average Price Target from Analysts - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

Quince Therapeutics (QNCX) Registers 17.34M Shares for Resale - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Quince Therapeutics Seeks to Resell 17.34M Shares, Analysts Predict 300% Upside Potential - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Quince Therapeutics (QNCX) Plans to Offer 6.67 Million Shares - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Is Quince Therapeutics Inc. a good long term investmentFree Stock Market Knowledge Sharing - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying Quince Therapeutics Inc. stock nowFree Market Dynamics Reports - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Can Quince Therapeutics Inc. stock recover from recent declineConsistent triple returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Quince Therapeutics Inc. Stock Analysis and ForecastMassive wealth growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Quince Therapeutics Inc. stockFree Stock Chart Pattern Guide - Autocar Professional

Jul 24, 2025

Quince Therapeutics Inc Stock (QNCX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):